Vaughan Nelson Investment Management L.P. Purchases New Position in Revvity Inc. $RVTY

Vaughan Nelson Investment Management L.P. bought a new position in Revvity Inc. (NYSE:RVTY) in the 1st quarter, Holdings Channel.com reports. The firm bought 461,265 shares of the company’s stock, valued at approximately $40,411,000.

A number of other large investors have also modified their holdings of the stock. JPMorgan Chase & Co. raised its position in shares of Revvity by 15.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 511,360 shares of the company’s stock valued at $44,821,000 after purchasing an additional 67,662 shares in the last quarter. Tudor Investment Corp ET AL acquired a new position in shares of Revvity in the 3rd quarter worth approximately $15,128,000. Neuberger Berman Group LLC increased its holdings in shares of Revvity by 4,598.9% in the 3rd quarter. Neuberger Berman Group LLC now owns 460,447 shares of the company’s stock valued at $40,358,000 after acquiring an additional 450,648 shares during the last quarter. Elo Mutual Pension Insurance Co increased its holdings in shares of Revvity by 46.2% in the 3rd quarter. Elo Mutual Pension Insurance Co now owns 19,199 shares of the company’s stock valued at $1,683,000 after acquiring an additional 6,066 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC raised its position in shares of Revvity by 127.0% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock valued at $171,921,000 after acquiring an additional 980,142 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Price Performance

Shares of RVTY opened at $100.47 on Monday. The company has a market cap of $11.21 billion, a P/E ratio of 48.07, a PEG ratio of 2.19 and a beta of 1.11. The stock has a fifty day moving average price of $96.02 and a 200 day moving average price of $97.58. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41. Revvity Inc. has a 12 month low of $81.22 and a 12 month high of $118.30.

Revvity (NYSE:RVTY) last issued its earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The firm had revenue of $711.12 million for the quarter, compared to analyst estimates of $704.07 million. During the same period last year, the company earned $1.01 earnings per share. The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, research analysts forecast that Revvity Inc. will post 5.25 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be given a $0.07 dividend. The ex-dividend date is Friday, July 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity’s dividend payout ratio (DPR) is currently 13.40%.

Wall Street Analysts Forecast Growth

RVTY has been the topic of several research analyst reports. Weiss Ratings cut Revvity from a “sell (d+)” rating to a “sell (d)” rating in a research note on Wednesday, May 13th. Barclays boosted their target price on shares of Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. JPMorgan Chase & Co. dropped their target price on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a report on Wednesday, May 6th. Robert W. Baird set a $117.00 price target on shares of Revvity in a research report on Wednesday, May 6th. Finally, Wall Street Zen lowered shares of Revvity from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. Four analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Revvity currently has an average rating of “Hold” and a consensus target price of $107.73.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.